Aurio Pharma Laboratories Private Limited

Aurio Pharma Laboratories Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
CIN U85195WB1998PTC086879 Incorporated 30 March 1998 ROC Kolkata HQ Kolkata, West Bengal, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹27.02 Cr
▼ 9% YoY
Net profit · FY 2025
₹26.62 Lakh
Net margin 1%
EBITDA · FY 2025
₹1.08 Cr
EBITDA margin 4%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹16.79 Lakh
Issued & subscribed
Open charges
₹8.6 Cr
Satisfied ₹3 Cr
Company age
28 yrs
Est. 1998
Employees · EPFO
114
Provident fund records

About Aurio Pharma Laboratories Private Limited

Data last updated:

Aurio Pharma Laboratories Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 March 1998 and has been in existence for over 28 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U85195WB1998PTC086879. Its GSTIN is 19AACCA6212B1Z9 (West Bengal).

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹16.79 Lakh. It is led by directors Santosh Bhattacharya and Mandira Bhattacharjee.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 285/5 Jawpur Road Dum, Kolkata, West Bengal, India – 700074.

As per the financials filed for FY 2025, the company reported a revenue of ₹27.02 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹26.62 Lakh (net margin 1%) and EBITDA of ₹1.08 Cr (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 2% over five years.

The company has about 114 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Aurio Pharma Laboratories. As per MCA filings, the company has open charges of ₹8.6 Cr and satisfied charges of ₹3 Cr on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it; 3 cases are pending.

Aurio Pharma Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-14-0002340). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website auriopharma.com.

Company details

CIN U85195WB1998PTC086879
Registration Number 086879
Incorporation Date 30 March 1998
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-WB-14-0002340

Recognitions & Rankings of Aurio Pharma Laboratories

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-WB-14-0002340

Contact details

Aurio Pharma Laboratories Private Limited's registered office is in Kolkata, West Bengal. Its website is auriopharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    285/5 Jawpur Road Dum, Kolkata, West Bengal, India – 700074
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Aurio Pharma Laboratories Private Limited, buy the company report.

Comprehensive company report
Aurio Pharma Laboratories Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Aurio Pharma Laboratories operates one associated brand: Aurio Pharma Laboratories. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures and markets pharmaceutical drugs, including syrups and tablets, in Eastern India.auriopharma.com

Business activity

The main business activity of Aurio Pharma Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Aurio Pharma Laboratories Private Limited, buy the company report.

Financials of Aurio Pharma Laboratories Private Limited

FY 2025 filings available

Aurio Pharma Laboratories Private Limited reported revenue of ₹27.02 Cr (down 9% YoY) for FY 2025.

Revenue · FY 2025
₹27.02 Cr ▼ 9%
Net profit · FY 2025
₹26.62 Lakh margin 1%
EBITDA · FY 2025
₹1.08 Cr margin 4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 17%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▼ 8%
5 years · compounded
▼ 3%

Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.08 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹26.62 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4%
Net Profit Margin1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Aurio Pharma Laboratories Private Limited, buy the company report.

Board of directors of Aurio Pharma Laboratories Private Limited

Aurio Pharma Laboratories has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Santosh BhattacharyaDirector30 Mar 199828 Years 6 MonthsCurrent
Mandira BhattacharjeeDirector18 Aug 199927 Years 2 MonthsCurrent

Peer comparison

Aurio Pharma Laboratories Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sun Moon Pharmaceuticals Private Limited₹27.19 Cr (FY 2025)48.0%Boisar, Maharashtra, India
HBC Healthcare Private Limited₹27.06 Cr (FY 2024)288.0%Gandhinagar, Gujarat, India
Aurio Pharma Laboratories Private Limitedthis company₹27.02 Cr (FY 2025)₹26.62 Lakh1%-9.0%114Kolkata, West Bengal, India
Orley Laboratories Private Limited₹27.02 Cr (FY 2025)19.0%Ahmedabad, Gujarat, India
God Gift Laboratory Private Limited₹26.95 Cr (FY 2025)-7.0%Punjabi Bagh, Delhi, India
Elikem Pharmaceuticals Private Limited₹26.94 Cr (FY 2025)14.0%Kalol, Gujarat, India

To see the full peer comparison of Aurio Pharma Laboratories Private Limited, buy the company report.

Auditor

Aurio Pharma Laboratories Private Limited is audited by GIRDHARI SHARMA & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
GIRDHARI SHARMA & COFY 2023312171E

Shareholding

The shareholding of Aurio Pharma Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Aurio Pharma Laboratories Private Limited, buy the company report.

Charges & borrowings

Open charges
₹8.6 Cr
Satisfied charges
₹3 Cr
Breakdown by lending institutions
Axis Bank Limited₹8.60 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Jun 2018100193283Axis Bank Limited₹8.6 CrOpen
22 Jun 199890245395Bank of Baroda₹3 CrSatisfied

To see the full charge records of Aurio Pharma Laboratories Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Aurio Pharma Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Aurio Pharma Laboratories Private Limited has a workforce of 114 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.

Employee count
114
Active EPFO establishments
1
Employee growth
-0.87%

GST

Aurio Pharma Laboratories has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
19AACCA6212B1Z9West BengalActive01 Jul 2017

To see the full GST registrations and return filing status of Aurio Pharma Laboratories Private Limited, buy the company report.

Recent activity

Aurio Pharma Laboratories Private Limited has 3 board changes on record since 1998: 2 appointments and 1 cessation. The latest: Arati Prova Bhattacharjee ceased to be Director on 11 Nov 2016.

AGM
Aurio Pharma Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited of Rs. 860.00 Lakh registered on 30 Jun 2018 with Charge ID 100193283 was modified on 16 Sep 2025.
Filing
Aurio Pharma Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Charges
A charge registered on 22 Jun 1998 via Charge ID 90245395 with Bank Of Baroda was fully satisfied on 13 Jul 2018.
Charges
A charge with Axis Bank Limited amounted to Rs. 860.00 Lakh with Charge ID 100193283 was registered on 30 Jun 2018.
Ceased
Arati Prova Bhattacharjee ceased to be Director.
Charges
A charge with Bank Of Baroda of Rs. 300.00 Lakh registered on 22 Jun 1998 with Charge ID 90245395 was modified on 23 Apr 2014.
Appointed
Mandira Bhattacharjee was appointed as Director.
Charges
A charge with Bank Of Baroda amounted to Rs. 300.00 Lakh with Charge ID 90245395 was registered on 22 Jun 1998.
Appointed
Santosh Bhattacharya was appointed as Director.
Incorporation
30 Mar 1998
Aurio Pharma Laboratories Private Limited was registered on 30 Mar 1998 with Roc Kolkata & aged 28 years 7 months as per MCA records.

Frequently asked questions

Aurio Pharma Laboratories is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 March 1998 (28+ years old) and is registered under CIN U85195WB1998PTC086879.

Aurio Pharma Laboratories has 2 current directors:

The latest financial statements of Aurio Pharma Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Aurio Pharma Laboratories is 19AACCA6212B1Z9, registered in West Bengal.

The CIN (Corporate Identification Number) of Aurio Pharma Laboratories is U85195WB1998PTC086879. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Aurio Pharma Laboratories has 5 court cases on record: 3 filed by the company and 2 filed against it. 3 are pending. Most are in the high courts.

Aurio Pharma Laboratories was incorporated on 30 March 1998, making it 28+ years old. It is registered with the Registrar of Companies, Kolkata.

The peers of Aurio Pharma Laboratories by revenue are Sun Moon Pharmaceuticals Private Limited, HBC Healthcare Private Limited, Orley Laboratories Private Limited, God Gift Laboratory Private Limited, Elikem Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Arati Prova Bhattacharjee ceased to be Director on 11 Nov 2016. Mandira Bhattacharjee was appointed as Director on 18 Aug 1999. Santosh Bhattacharya was appointed as Director on 30 Mar 1998.

Yes, Aurio Pharma Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-WB-14-0002340).

Aurio Pharma Laboratories can be reached through the website auriopharma.com. Its registered office is in Kolkata, West Bengal, India.